期刊文献+

某三甲妇儿医院注射剂说明书中儿童用药信息标注情况的调查与分析

Investigation and Analysis of Child Medication Information in the Injection Manual of a Third A Women and Children’s Hospital
下载PDF
导出
摘要 目的调查某三甲妇儿医院里注射剂药品说明书中关于儿童用药信息的标注情况,分析该院儿童患者临床使用注射剂的用药风险。方法通过医院信息系统统计注射剂品种285种,收集对应说明书,采用文本分析法分析儿童用药信息标注情况。结果对说明书进行统计分析,其中国产药品246种(86.32%),进口药品39种(13.68%)。有儿童用药信息的注射剂共277种,占比97.19%,无儿童用药信息的注射剂共8种,占比2.81%,其中儿童专用注射剂品种仅有2种,占比0.7%。结论注射剂中儿童专用药品较少,儿童临床试验开展极少,导致儿童用药信息标注不充分,儿童用药存在安全隐患。 Objective To investigate the labeling of child medication information in the injection instructions in a third grade women and children’s hospital,and analyze the risk of clinical use of injections in pediatric patients in the hospital.Methods 285 injection varieties were counted through the hospital information system,corresponding instructions were collected and child drug information annotation was analyzed by text analysis.Results Statistical analysis of the instructions,including 246 domestic drugs(86.32%)and 39 imported drugs(13.68%).There were 277 injections with medication information for children,accounting for 97.19%,and 8 injections without child medication information,accounting for 2.81%,including only 2 special injections for children,accounting for 0.7%.Conclusion Few drugs for children,few clinical trials,resulting to insufficient information and safety risks.
作者 陈家晟 CHEN Jiasheng(Xiamen Maternal and Child Health Hospital/Department of Pharmacy,Women and Children's Hospital Affiliated to Xiamen University,Xiamen,Fujian 361003)
出处 《智慧健康》 2022年第5期104-106,共3页 Smart Healthcare
基金 2020年中国药学会科技开发中心立项课题(课题编号:CMEI2020KPYJ00522)。
关键词 注射剂 药品说明书 儿童 信息 风险 Injection Drug instructions Children Information Risk
  • 相关文献

参考文献7

二级参考文献48

  • 1国家食品药品监督管理局.药物临床试验机构认定公告[EB/OL].http://www.sda.gov.cn/WS01/CL0069/,2010-01-22.2010-04-22.
  • 2国家食品药品监督管理局.药品说明书和标签管理规定[局令第 24 号][EB/OL]. 2006-03-15.http://www.sda.gov.cnAVS01/CL0053/24522.html.
  • 3Cuzzolin L, Zaccaron A, Fanos V (2003) Unlicensed and off-label uses of drugs in paediatrics: a review of the literature [J].Fundam Clin Pharmacol, 2003,17(1):125-131.
  • 4Conroy S , Choonara I,Impicciatore P , et al . Survey ofunlicensed and off label drug use in pediatric wards inEuropean countries [J]. BMJ,2000,320(7227) :79-82.
  • 5Pandolfini C, Bonati M. A literature review on off-label druguse in children[J]. Eur J Pediatr, 2005,164(9):5521.
  • 6FDA. Title V -Best Pharmaceuticals for Children Act of 2007 [EB/OL]. [2016-05-28]. http://www.fda.gov/downloads/Drugs/ DevelopmentApprovalProcess/Deve|opmentResources/ UCMO49870.pdf.
  • 7FDA. TitleiV-Pediatric Research Equity Act of 2007 [EB/OL] [ 2016-05-28 ]. http://www, fda.gov/downloads/Drugs/Developme- ntApprovalProcess/DevelopmentResources/UCM049870.pdf.
  • 8FDA. FDASIA[EB/OL]. [2016-05-28]. http://www.fda.gov/Reg- ulatoryInformation/Legislation/SignificantAmendmentstotheFDC - Act/FDASIA/defauh.htm.
  • 9FDA. Office of Pediatric Therapeutics [EB/OL]. [2016-05-28]. http ://www.fda.gov/aboutfda/centersoffices/officeofmedicalprod - uctsandtobacco/officeofscienceandhealthcoordination/ucm20181 86.htm.
  • 10FDA. The Pediatric Exclusivity Provision [EB/OL]. [2016-05- 28]. http ://www.fda.gov/downloads/drugs/developmentapproval- process/developmentresources/ucm049915.pdf.

共引文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部